MedTrace Logo

Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors

NCT02233842 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2016-09-12

Study results available
· View outcomes & findings →

Summary

Background:

\- People who have cancer have more medical problems if they smoke. Some studies show that smoking even makes cancer treatment less effective. Researchers want to teach people about how tobacco use affects people after a cancer diagnosis. They want to come up with questions for people who have cancer and who have survived cancer. The questions will be about using cigarettes and other tobacco products and about second-hand smoke.

The questions will be used to understand how using tobacco affects people with cancer before, during, and after treatment. This will help doctors plan how to treat people with cancer and create programs to help people quit smoking in the future.

Objective:

\- To evaluate and refine questions that assess tobacco use.

Eligibility:

\- Adults age 21 or older who have cancer or are cancer survivors. The cancer can be at any site and any stage.

Design:

* This study will take about 1 hour.
* Participants will meet one-on-one with an interviewer. They will fill out a questionnaire and talk about the questions. Participants will explain how easy or hard it was to answer the questions and how they decided on their answers.
* All participants will be asked the same or very similar questions. Specific questions will be based on the participants own experiences with tobacco products.
* There will be no follow-up activities.

Conditions

Interventions

BEHAVIORAL

Participant interview

People with cancer and who have survived cancer will have a 1 hour interview about using cigarettes and other tobacco products.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • Stephanie R. Land, Ph.D. · National Cancer Institute (NCI)

Eligibility

Min Age
21 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02233842 on ClinicalTrials.gov